SCHEMBL20484292

SCHEMBL20484292

CCCCCCCC/C=C\CCCCCCCC(=O)OP(=O)(O)OC(=O)CCCCCCC/C=C\CCCCCCCC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 5/20 0.59
LPAR1 Q92633 5/20 0.57
ENPP2 Q13822 2/20 0.57
LPAR4 Q99677 2/20 0.57
LPAR5 Q9H1C0 2/20 0.57
LPAR2 Q9HBW0 2/20 0.57
LPAR3 Q9UBY5 2/20 0.57
CES2 O00748 1/20 0.57
LPAR6 P43657 1/20 0.57
TRPV1 Q8NER1 1/20 0.57
TERT O14746 3/20 0.56
CYP1A2 P05177 2/20 0.56
MAPT P10636 2/20 0.56
CYP2C19 P33261 2/20 0.56
BLM P54132 2/20 0.56
HSD17B10 Q99714 2/20 0.56
FABP4 P15090 2/20 0.56
FAAH O00519 2/20 0.56
PTPN1 P18031 2/20 0.56
PPARG P37231 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3888681 1.00 FABP3 (0.59) FABP3LPAR1ENPP2LPAR4LPAR5
SCHEMBL22802111 1.00 FABP3 (0.59) FABP3LPAR1ENPP2LPAR4LPAR5
SCHEMBL305874 0.92 ENPP2 (0.55) FABP3LPAR1ENPP2LPAR4LPAR5
SCHEMBL27647304 0.92 ENPP2 (0.55) FABP3LPAR1ENPP2LPAR4LPAR5
SCHEMBL10478921 0.91 LPAR1 (0.55) FABP3LPAR1ENPP2LPAR4LPAR5
SCHEMBL340006 0.91 LPAR1 (0.55) FABP3LPAR1ENPP2LPAR4LPAR5
SCHEMBL28547666 0.91 LPAR1 (0.55) FABP3LPAR1ENPP2LPAR4LPAR5
SCHEMBL193956 0.90 LPAR1 (0.60) FABP3LPAR1ENPP2LPAR4LPAR5
SCHEMBL18123890 0.90 LPAR1 (0.60) FABP3LPAR1ENPP2LPAR4LPAR5
SCHEMBL22802118 0.90 LPAR1 (0.60) FABP3LPAR1ENPP2LPAR4LPAR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2794021-B1 COLORING AGENT COMPRISING DIRECT DYES AND PHOSPHATE SURFACTANTS HENKEL AG & CO KGAA (DE) 2018-09-05 EP claimed
CN-122012161-A Seamless textile machinery lubricating oil and preparation method thereof 浙江传化化学品有限公司 2026-05-12 CN disclosed
US-12565510-B2 Phospholipid NIPPON FINE CHEMICAL CO., LTD. (JP) 2026-03-03 US disclosed
CN-116196293-B Enteric lignin bacteria embedded particles for treating ulcerative colitis and preparation thereof 华南理工大学 2025-05-02 CN disclosed
US-12122861-B2 Multi-component copolymer, rubber composition, resin composition, tire, and resin product BRIDGESTONE CORPORATION (JP) 2024-10-22 US disclosed
CN-114853806-B Preparation method of 1, 2-dioleoyl-SN-glycerinum-3-phosphorylethanolamine 苏州昊帆生物股份有限公司 2024-03-29 CN disclosed
EP-4306531-A1 PHOSPHOLIPID Nippon Fine Chemical Co., Ltd. (JP) 2024-01-17 EP disclosed
CN-116889524-A Hair-blacking composition based on polydioxindole liposome and preparation method and application thereof 泉后(广州)生物科技研究院有限公司 2023-10-17 CN disclosed
US-20230312620-A1 PHOSPHOLIPID NIPPON FINE CHEMICAL CO., LTD. (JP) 2023-10-05 US disclosed
US-20230295199-A1 PHOSPHOLIPID NIPPON FINE CHEMICAL CO., LTD. (JP) 2023-09-21 US disclosed
CN-116157117-A Phospholipid 日本精化株式会社 2023-05-23 CN disclosed
WO-2022259958-A1 PHOSPHOLIPID 日本精化株式会社 2022-12-15 WO disclosed
WO-2022190967-A1 PHOSPHOLIPID 日本精化株式会社 2022-09-15 WO disclosed
CN-114853806-A Preparation method of 1, 2-dioleoyl-SN-glycerol-3-phosphorylethanolamine 苏州昊帆生物股份有限公司 2022-08-05 CN disclosed
US-20220213240-A1 MULTI-COMPONENT COPOLYMER, RUBBER COMPOSITION, RESIN COMPOSITION, TIRE, AND RESIN PRODUCT BRIDGESTONE CORPORATION (JP) 2022-07-07 US disclosed
CN-110506047-B Lipid derivative for nucleic acid introduction 日本精化株式会社 2022-06-17 CN disclosed
EP-3970989-A1 MULTI-COMPONENT COPOLYMER, RUBBER COMPOSITION, RESIN COMPOSITION, TIRE, AND RESIN PRODUCT BRIDGESTONE CORPORATION (JP) 2022-03-23 EP disclosed
CN-110506047-A Lipid derivate is used in nucleic acid importing NIPPON FINE CHEMICAL CO 2019-11-26 CN disclosed
CN-105131067-B RNA in skin and fibrotic conditions is interfered 雷克西制药公司 2019-02-19 CN disclosed
CN-1195981-A Inverse Fluorocarbon Emulsion Compositions for Drug Delivery ALLIANCE PHARMA (US) 1998-10-14 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12565510-B2 Phospholipid RNASEH1, PHOSPHO1, RNASE1 FABP3 2768/4885LPAR1 16/4885ENPP2 296/4885
US-20230295199-A1 PHOSPHOLIPID PHOSPHO1, PLTP, SGMS1 FABP3 146/4885LPAR1 8/4885ENPP2 181/4885
US-20230312620-A1 PHOSPHOLIPID PHOSPHO1, SGMS1, PLTP FABP3 775/4885LPAR1 5/4885ENPP2 68/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.